Skip to the content

News

IN VITRO SCIENCES NAMES DEREK LARKIN AS NEW CHIEF EXECUTIVE OFFICER

Avon, Connecticut, May 20, 2020 - The In Vitro Sciences (IVS) Board of Directors announced today the placement of Derek M. Larkin as Chief Executive Officer. This appointment follows a recapitalization event by private equity firm, Sverica Capital Management, LP (Boston and San Francisco) and helps set IVS up for continued national expansion. During the past year IVS, a prominent network of fertility centers, also completed a spin-out from Women’s Health USA and acquired Advanced Fertility Care, ...